Benefits of Colostrum

Evidence-Based Benefits

• NSAID gut protection — Playford et al. (2001, n=7, crossover RCT) demonstrated bovine colostrum prevented the 3-fold increase in intestinal permeability caused by indomethacin (NSAID)
• Gut barrier in athletes — Marchbank et al. (2011, n=12) found bovine colostrum (20g/day × 14 days) prevented the rise in intestinal permeability caused by heavy exercise in hot conditions
• Immune support — bovine colostrum IgG survives gastric transit and provides passive immune defense in the GI tract; Saad et al. (2016) reviewed evidence for preventing GI infections
• Growth factor delivery — colostrum contains IGF-1 and TGF-beta which promote intestinal epithelial cell proliferation and mucosal repair (Playford et al., 2000)

What the Research Says

Colostrum is a nutrient-rich milk produced by mammals immediately after birth, with bovine colostrum being a common source for human supplementation. It contains immunoglobulins, growth factors, and other bioactive compounds that support immune function and gut health. Research indicates that bovine colostrum has moderate clinical evidence for gut barrier support, particularly in reducing exercise-related gut permeability (Marchbank et al., 2011). Additionally, it has been shown to mitigate the increase in intestinal permeability caused by non-steroidal anti-inflammatory drugs (NSAIDs) (Playford et al., 2001).

Recent studies have highlighted the potential benefits of colostrum in neonatal care. A systematic review and meta-analysis of 21 studies involving 2393 preterm neonates found that oropharyngeal colostrum therapy significantly reduces culture-proven sepsis (RR: 0.78, 95% CI: 0.65-0.94) with high certainty of evidence (Anne et al., 2024). Similarly, a meta-analysis of 17 RCTs involving 4106 preterm infants demonstrated that oropharyngeal application of colostrum/mother's milk reduces sepsis, necrotizing enterocolitis (NEC), and accelerates enteral feeding initiation (Kumar et al., 2023).

Despite these benefits, limitations remain. Small study sizes, variability in product quality, and the insufficient survival of IgG through gastric transit for systemic immunity are notable concerns. Furthermore, heat treatment of colostrum can reduce immunoglobulin concentrations, although this may increase serum immunoglobulins (Malik et al., 2022). Overall, while colostrum shows promise in gut barrier protection and neonatal care, further research is needed to address these limitations and optimize its therapeutic applications.

Related Conditions